Incyte
INCY
#1215
Rank
S$24.20 B
Marketcap
S$121.64
Share price
-0.54%
Change (1 day)
55.57%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2025 (TTM): S$8.51

According to Incyte's latest financial reports the company's current EPS (TTM) is S$8.40. In 2024 the company made an earnings per share (EPS) of S$0.39 a decrease over its 2023 EPS that were of S$3.40.

EPS history for Incyte from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$8.512056.05%
2024S$0.39-88.39%
2023S$3.4073.38%
2022S$1.96-64.1%
2021S$5.46-408.63%
2020S-$1.77-166.83%
2019S$2.65300%
2018S$0.66-133.33%
2017S-$1.99-378.57%
2016S$0.712700%
2015S$0.02546-106.67%
2014S-$0.38-44.44%
2013S-$0.6950%
2012S-$0.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
S$9.17 9.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$1.73-79.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$29.31 248.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.24 117.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$8.02-4.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
S-$0.15-101.82%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
S-$0.74-108.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
S-$1.07-112.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
S-$0.29-103.48%๐Ÿ‡บ๐Ÿ‡ธ USA